Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Nimzing, L."'
Autor:
Cosmas NT; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria., Nimzing L; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria.; Department of Medical Laboratory Science, College of Health Sciences, University of Jos, Jos, Nigeria., Egah DZ; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria.; Department of Medical Microbiology, Jos University Teaching Hospital, Jos, Nigeria., Famooto OA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, 660 West Redmond Street, Baltimore, MD, 21201, USA., Adebamowo SN; Department of Epidemiology and Public Health, University of Maryland School of Medicine, 660 West Redmond Street, Baltimore, MD, 21201, USA.; The Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Adebamowo CA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, 660 West Redmond Street, Baltimore, MD, 21201, USA. cadebamowo@som.umaryland.edu.; The Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA. cadebamowo@som.umaryland.edu.
Publikováno v:
BMC research notes [BMC Res Notes] 2023 Oct 14; Vol. 16 (1), pp. 272. Date of Electronic Publication: 2023 Oct 14.
Publikováno v:
The Journal of Infectious Diseases, 2010 Sep 01. 202, S64-S71.
Externí odkaz:
https://www.jstor.org/stable/25707005
Autor:
Cosmas NT; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria., Nimzing L; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria.; Department of Medical Laboratory Science, College of Health Sciences, University of Jos, Jos, Nigeria., Egah D; Department of Medical Microbiology, College of Health Sciences, University of Jos, Jos, Nigeria.; Department of Medical Microbiology, Jos University Teaching Hospital, Jos, Nigeria., Famooto A; Institute of Human Virology Nigeria, Abuja, Nigeria., Adebamowo SN; Department of Epidemiology and Public Health, and the Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 660 West Redmond Street, Baltimore, MD, 21201, USA., Adebamowo CA; Institute of Human Virology Nigeria, Abuja, Nigeria. cadebamowo@som.umaryland.edu.; Department of Epidemiology and Public Health, and the Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 660 West Redmond Street, Baltimore, MD, 21201, USA. cadebamowo@som.umaryland.edu.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2022 Apr 05; Vol. 22 (1), pp. 340. Date of Electronic Publication: 2022 Apr 05.
Publikováno v:
IOSR Journal of Dental and Medical Sciences. 13:78-82
Background: Human Immunodeficiency Virus (HIV) is a global phenomenon with an estimated population of 7.7% infected people in Plateau state, Nigeria. Aim: This study was aimed at monitoring the effectiveness of Anti-retroviral Therapy (ART) on HIV-1
Autor:
Anejo-Okopi, JA, Agbaji, OO, Agaba, PA, Ugoagwu, PO, Were, K, Onywera, H, Owiti, P, Isa, SE, Otecko, N, Okwori, AEJ, Musa, J, Oguche, S, Sagay, AS, Idoko, JA, Nimzing, L, Jatau, ED, Olonitola, OS
Publikováno v:
African Journal of Biotechnology; Vol 12, No 17 (2013)
The presence of human immunodeficiency virus (HIV) type-1 diversity has an impact on vaccine efficacy and drug resistance. It is important to know the circulating genetic variants and associated drug-resistance mutations in the context of scale up of
Autor:
Adepoju, Victor Abiola1 (AUTHOR) victor.adepoju@jhpiego.org, Udah, Donald Chinazor2,3 (AUTHOR) donald.udah@gmail.com, Adnani, Qorinah Estiningtyas Sakilah4 (AUTHOR) qorinah.adnani@unpad.ac.id
Publikováno v:
Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1723. 15p.
Autor:
Anejo-Okopi, JA, Agaba, PA, Agbaji, OO, Onywera, H, Agaba, EI, Oguche, S, Nimzing, L, Olonitola, SO
Publikováno v:
Highland Medical Research Journal; Vol 13, No 2 (2013); 90-93
Background: The ability to differentiate recent human immunodeficiency virus infections (infection within few months) from long-standing (established) infection is valuable for accurate measurement of the changing patterns of HIV transmission and dis
Autor:
Chukwuedo, AA, Nimzing, L
Publikováno v:
Nigerian Journal of Biotechnology; Vol 24 (2012)
The prevalence of FMD virus serotypes SAT 1 and SAT 2 among Nigerian cattle was determined using Complement Fixation (CF) and Serum Neutralization (SN) Tests in 2000 cattle sera obtained from nine northern states. The disease prevalence by CF and SN
Publikováno v:
International Journal of Natural and Applied Sciences; Vol 5, No 4 (2009)
The prevalences of hepatitis B virus surface antigen (HBsAg) and hepatitis C virus (HCV) antibodies were determined in 560 blood donors sera using ELISA kits (DIALAB., Austria). Forty eight (8.57%) of these were positive for hepatitis B virus infecti
Autor:
Chukwuedo, AA, Nimzing, L
Publikováno v:
Animal Production Research Advances; Vol 7, No 1 (2011); 32-36
In this study the potency of killed Foot and Mouth Disease (FMD) vaccines serotypes SAT1 (Nig 1/98) and SAT 2 (Nig 2/97) virus isolates, formulated with montanide ISA 206 adjuvant was determined in guinea pigs and cattle by antibody assay using Compl